- Release Date: 19/12/24 09:41
- Summary: SPL receives positive FDA feedback on DEP SN38 for PROC
- Price Sensitive: Yes
- Download Document 166.7KB
- Forums
- ASX - By Stock
- SPL
- Ann: SPL receives positive FDA feedback on DEP SN38 for PROC
SPL
starpharma holdings limited
Add to My Watchlist
3.41%
!
9.1¢

Ann: SPL receives positive FDA feedback on DEP SN38 for PROC
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.1¢ |
Change
0.003(3.41%) |
Mkt cap ! $38.89M |
Open | High | Low | Value | Volume |
8.8¢ | 9.3¢ | 8.8¢ | $104.5K | 1.156M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 71962 | 9.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 49584 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 71962 | 0.091 |
1 | 199389 | 0.090 |
2 | 200000 | 0.089 |
3 | 493045 | 0.088 |
1 | 242267 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 49584 | 2 |
0.094 | 50000 | 1 |
0.095 | 70642 | 5 |
0.099 | 280650 | 10 |
0.100 | 33250 | 6 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online